Figure 7.
Molecular imaging using radiolabeled iron oxide nanoparticles. A) Representative in vivo near infrared images of U87MG tumor-bearing mice at 1 h, 4 h and 18 h p.i. of 64Cu-labeled iron oxide nanoparticles; B) representative in vivo PET images results of U87MG tumor-bearing mice at 1 h, 4 h and 18 h p.i. of 64Cu-labeled iron oxide nanoparticles; C) representative MRI images of U87MG tumor-bearing mice acquired before and 18 h p.i. Adapted from Xie et al.82